I am a negative symptom of schizophrenia. I describe decreased emotional expression, where the patient’s facial expressions become flat and voice monotone.

I am a first-generation antipsychotic commonly used for acute psychosis. I carry a high risk of extrapyramidal symptoms (EPS) because I block dopamine strongly.

I am a second-generation antipsychotic. I treat both positive and negative symptoms, with less risk of EPS, but I can cause metabolic syndrome (weight gain, diabetes, dyslipidemia).

I am reserved for treatment-resistant schizophrenia due to my risk of agranulocytosis. I require regular WBC/ANC monitoring.

I am a tool clinicians use to check for involuntary movements caused by antipsychotics. I monitor for symptoms of tardive dyskinesia.

I am a personality disorder. People with me show instability in relationships, identity disturbance, impulsivity, self-harm behaviors, and fear of abandonment.

I am a personality disorder defined by a need for admiration, lack of empathy, and a grandiose sense of self-importance.

I am a dissociative disorder where the individual travels away suddenly and cannot recall their identity or past.

I am a dissociative disorder. A patient feels detached from their body or surroundings, like they are watching themselves in a dream.

I am a somatic illness disorder in which a patient is preoccupied with having a serious medical disease despite negative test results and continued reassurance.

I am a somatic illness disorder where symptoms affect voluntary motor or sensory functions (such as sudden blindness or paralysis) but are not explained medically. Symptoms are often linked to psychological stress.

I am a somatic disorder where the patient truly experiences distressing physical symptoms, but the focus on these symptoms is excessive and disproportionate compared to medical findings.